![Updated version of my Ynglingatal poster, with much better colors, fixed alliterations, and expanded notes, and other small changes. : r/Norse Updated version of my Ynglingatal poster, with much better colors, fixed alliterations, and expanded notes, and other small changes. : r/Norse](https://preview.redd.it/id2uy1xd09l61.png?auto=webp&s=432812e8919bd149044fe02b2ff1c29c2fb88d73)
Updated version of my Ynglingatal poster, with much better colors, fixed alliterations, and expanded notes, and other small changes. : r/Norse
![Oxaliplatin‐induced enteric neuronal loss and intestinal dysfunction is prevented by co‐treatment with BGP‐15 - McQuade - 2018 - British Journal of Pharmacology - Wiley Online Library Oxaliplatin‐induced enteric neuronal loss and intestinal dysfunction is prevented by co‐treatment with BGP‐15 - McQuade - 2018 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/f622d469-ce4b-4eea-9222-2b4a51208636/bph.v175.4.cover.jpg)
Oxaliplatin‐induced enteric neuronal loss and intestinal dysfunction is prevented by co‐treatment with BGP‐15 - McQuade - 2018 - British Journal of Pharmacology - Wiley Online Library
![tup AM and TARM mutant phenotypes and org-1>tup epistasis. (A-B′) Stage... | Download Scientific Diagram tup AM and TARM mutant phenotypes and org-1>tup epistasis. (A-B′) Stage... | Download Scientific Diagram](https://www.researchgate.net/publication/265508664/figure/fig4/AS:614184253419566@1523444345742/tup-AM-and-TARM-mutant-phenotypes-and-org-1tup-epistasis-A-B-Stage-15-org-1-lacZ-A.png)
tup AM and TARM mutant phenotypes and org-1>tup epistasis. (A-B′) Stage... | Download Scientific Diagram
![Frontiers | Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine Frontiers | Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine](https://www.frontiersin.org/files/Articles/1059579/fcell-10-1059579-HTML-r1/image_m/fcell-10-1059579-g001.jpg)
Frontiers | Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine
![6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial - The Lancet 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial - The Lancet](https://www.thelancet.com/cms/attachment/acb101b5-5148-4a6e-a0e2-89046185ffb8/gr2_lrg.jpg)
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial - The Lancet
![Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer - eBioMedicine Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer - eBioMedicine](https://www.thelancet.com/cms/asset/7ae19580-c7c4-453f-8426-2abfb8370158/gr1.jpg)
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer - eBioMedicine
![Frontiers | Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends Frontiers | Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends](https://www.frontiersin.org/files/Articles/866889/fonc-12-866889-HTML/image_m/fonc-12-866889-g001.jpg)